http://www.laboratorytalk.com/news/chb/chb000.html Chimera Biotec news releases on Laboratorytalk en-gb Copyright (C)2008 Pro-Talk Ltd. All rights reserved. Fri, 21 Nov 2008 08:00:00 UT Fri, 21 Nov 2008 08:00:00 UT http://www.pro-talk.com/images/protalklogo90.gif http://www.pro-talk.com/ 90 79 For the third time Chimera Biotec supports the scientific community with a contest on ultra-sensitive immunoassays: the third Immunolympics are open Mon, 02 Jun 2008 08:00:00 UT Chimera Biotec http://www.laboratorytalk.com/news/chb/chb108.html Companies agree to co-market the rapid generation of monoclonal antibodies by AbD Serotec and Chimera Biotec's complementary Imperacer assay technology for ultra-sensitive antigen detection Fri, 04 May 2007 08:00:00 UT Chimera Biotec http://www.laboratorytalk.com/news/chb/chb107.html Chimera Biotec joins the EU funded Edar project to adapt the Imperacer platform technology for the detection of novel biomarkers for the diagnosis of Alzheimer's disease Mon, 12 Mar 2007 08:00:00 UT Chimera Biotec http://www.laboratorytalk.com/news/chb/chb106.html Contest seeks to find potential solutions to today's scientific challenges using the highly sensitive chimera Imperacer technology Mon, 18 Dec 2006 08:00:00 UT Chimera Biotec http://www.laboratorytalk.com/news/chb/chb105.html Chimera Biotec's Ron Wacker addresses ultra-high sensitive immunoassay technology at the Association for Molecular Pathology annual meeting Wed, 29 Nov 2006 08:00:00 UT Chimera Biotec http://www.laboratorytalk.com/news/chb/chb104.html Steroids and other forms of illegal substance abuse are 1000 times easier to detect in athletes thanks to a new highly sensitive technology created by Chimera Biotec and German Sports University. Mon, 18 Sep 2006 08:00:00 UT Chimera Biotec http://www.laboratorytalk.com/news/chb/chb102.html AvTech Laboratories and Chimera Biotec sign agreement that combines Chimera's ultra-high sensitive immunoassay technology, Imperacer, with AvTech's expertise in state-of-the-art analytical service Mon, 18 Sep 2006 08:00:00 UT Chimera Biotec http://www.laboratorytalk.com/news/chb/chb103.html Antibodies by Design, a division of MorphoSys, Munich, and Chimera Biotec have announced the start of a co-marketing agreement between the two companies Mon, 27 Feb 2006 08:00:00 UT Chimera Biotec http://www.laboratorytalk.com/news/chb/chb101.html Scientists benefit from an ultra-sensitive technology improving the existing assays by simply exchanging the fluorophor or enzyme labelled antibody by a DNA-antibody conjugate Mon, 21 Mar 2005 08:00:00 UT Chimera Biotec http://www.laboratorytalk.com/news/chb/chb100.html